1. Home
  2. Live Updates
  3. European league against rheumatism

Live Breaking News & Updates on European league against rheumatism

Stay informed with the latest breaking news from European league against rheumatism on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in European league against rheumatism and stay connected to the pulse of your community

Specific Disease Factors Linked to Osteoporosis Risk in Patients With Systemic Sclerosis

Investigators assessed the prevalence of and risk factors for osteoporosis and fragility fractures among patients with systemic sclerosis. Age, specific disease-related elements, and treatment with glucocorticoids independently affect the risk for osteoporosis among patients with SSc.

Department-of-internal-medicine , Lille-university-hospital , Internal-medicine , Lille-university , European-league-against-rheumatism ,

Abatacept Treatment May Slow Atherosclerosis Progression

Patients receiving abatacept experienced smaller increases in mean IMT, max IMT, and plaque score compared with the csDMARD cohorts.

Toho , Saga , Japan , Japanese , Arthritis-research-therapy , European-league-against-rheumatism , Toho-university-school-of-medicine , Arthritis-research , Toho-university-school ,

Tophi Duration, Drinking, Ulceration, and Serum Creatinine Linked to Bone Erosion in Gout

Researchers assessed the clinical characteristics and factors associated with bone erosion among patients with gout and tophi. Bone erosion in patients with gout and tophi was associated with tophi duration, drinking history, ulceration, and sCR levels.

American-college , European-league-against-rheumatism ,

Long-term Risankizumab Treatment Outperforms Placebo in PsA

Treatment with risankizumab was shown to be an effective strategy among patients with PsA regardless of varying demographic and psoriatic disease characteristics through 1 year.

Joseph-merola , Harvard-medical-school , Lupus-foundation-joseph-merola , Department-of-dermatology-at-brigham , European-league-against-rheumatism , American-college-of-rheumatology , Group-for-research , American-college-of-rheumatology-national-psoriasis-foundation , Lupus-foundation , Psoriatic-arthritis , American-college , National-psoriasis-foundation

Systemic Lupus Erythematosus

This review summarizes current evidence regarding the diagnosis, treatment, and prognosis of systemic lupus erythematosus.

United-states , American , Drug-administration , European-alliance-of-associations , European-league-against-rheumatism , American-college ,

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Australia , New-zealand , Maple-fung , Ono-pharmaceutical-co-ltd , Medicines-partnership , Equillium-inc , European-league-against-rheumatism , Biocon , European-renal-association , Lupus-network , Nasdaq , Ono-pharmaceutical

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, which may affect disease management and progression.

European-league-against-rheumatism , American-college-of-rheumatology , Hospital-anxiety , Depression-scale , American-college , Disease-activity-score , Clinical-disease-activity-index , Simplified-disease-activity , Ankylosing-spondylitis-disease-activity-score ,

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact psoriatic arthritis (PsA) treatment response and lead to higher rates of biologic disease-modifying antirheumatic drug (bDMARD) Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, which may affect disease management and progression.

American-college-of-rheumatology , European-league-against-rheumatism , Hospital-anxiety , Depression-scale , American-college , Disease-activity-score , Clinical-disease-activity-index , Simplified-disease-activity , Ankylosing-spondylitis-disease-activity-score ,

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, according to results.

American-college-of-rheumatology , European-league-against-rheumatism , Hospital-anxiety , Depression-scale , American-college , Disease-activity-score , Clinical-disease-activity-index , Simplified-disease-activity , Ankylosing-spondylitis-disease-activity-score ,

Fasting Plasma Glucose Linked to Myocardial Dysfunction in Gout

Findings provide a theoretical framework for the early diagnosis and treatment of heart disease in patients with gout, especially for older individuals and those with hypertension.

China , Chengdu , Sichuan , Chinese , American-college-of-rheumatology , European-league-against-rheumatism , Chengdu-medical-college , American-college ,